p53 expression in circulating lymphocytes of non-melanoma skin cancer patients from an arsenic contaminated region in Mexico. A pilot study.
D001151:Arsenic / Q000633:toxicity*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D008214:Lymphocytes / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008545:Melanoma / Q000378:metabolism; D008800:Mexico; D010865:Pilot Projects; D012878:Skin Neoplasms / Q000139:chemically induced / Q000453:epidemiology / Q000378:metabolism* / Q000473:pathology; D016159:Tumor Suppressor Protein p53 / Q000096:biosynthesis*; D014877:Water Pollution, Chemical / Q000009:adverse effects*
D016159:Tumor Suppressor Protein p53; D001151:Arsenic